if they get FDA approval your looking at a 50 stock. The only reason I'm throwing 50 out is because there are several other one drug oncology companies that have a stock price between 30-50 and there drugs wouldnt even do half the sales Genasense will do.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.